1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Chinese biotechnology market had total revenues of $23.2bn in 2020, representing a compound annual growth rate (CAGR) of 8.5% between 2016 and 2020.
- The medical/healthcare segment was the market's most lucrative in 2020, with total revenues of $12.2bn, equivalent to 52.6% of the market's overall value.
- It is expected that scientific advancement and technological innovation will continue to formulate a key component of China’s development goals as the country seeks to enhance its position as a superpower in the global economy. This is conducive to an attractive operating environment for biotech companies, supporting growth in the market.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in China
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in China
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the China biotechnology market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the China biotechnology market by value in 2020?
- What will be the size of the China biotechnology market in 2025?
- What factors are affecting the strength of competition in the China biotechnology market?
- How has the market performed over the last five years?
- Who are the top competitors in China's biotechnology market?
Note: Product cover images may vary from those shown
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?
7.5. How might the COVID-19 pandemic affect the competitive landscape?
8 Company Profiles
8.1. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
8.2. Shanghai Kehua Bio-engineering Co Ltd
8.3. Sinovac Biotech Ltd.
8.4. Novo Nordisk A/S
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related Research
10.4. About the Author
List of Tables
Table 1: China biotechnology industry value: $ billion, 2016-20
Table 2: China biotechnology industry category segmentation: $ billion, 2020
Table 3: China biotechnology industry geography segmentation: $ billion, 2020
Table 4: China biotechnology industry value forecast: $ billion, 2020-25
Table 5: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: key facts
Table 6: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Annual Financial Ratios
Table 7: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Key Employees
Table 8: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 9: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 10: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 11: Sinovac Biotech Ltd.: key facts
Table 12: Sinovac Biotech Ltd.: Annual Financial Ratios
Table 13: Sinovac Biotech Ltd.: Key Employees
Table 14: Novo Nordisk A/S: key facts
Table 15: Novo Nordisk A/S: Annual Financial Ratios
Table 16: Novo Nordisk A/S: Key Employees
Table 17: Novo Nordisk A/S: Key Employees Continued
Table 18: China size of population (million), 2016-20
Table 19: China gdp (constant 2005 prices, $ billion), 2016-20
Table 20: China gdp (current prices, $ billion), 2016-20
Table 21: China inflation, 2016-20
Table 22: China consumer price index (absolute), 2016-20
Table 23: China exchange rate, 2016-20
List of Figures
Figure 1: China biotechnology industry value: $ billion, 2016-20
Figure 2: China biotechnology industry category segmentation: % share, by value, 2020
Figure 3: China biotechnology industry geography segmentation: % share, by value, 2020
Figure 4: China biotechnology industry value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the biotechnology industry in China, 2020
Figure 6: Drivers of buyer power in the biotechnology industry in China, 2020
Figure 7: Drivers of supplier power in the biotechnology industry in China, 2020
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in China, 2020
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in China, 2020
Figure 10: Drivers of degree of rivalry in the biotechnology industry in China, 2020
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?
7.5. How might the COVID-19 pandemic affect the competitive landscape?
8 Company Profiles
8.1. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
8.2. Shanghai Kehua Bio-engineering Co Ltd
8.3. Sinovac Biotech Ltd.
8.4. Novo Nordisk A/S
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related Research
10.4. About the Author
List of Tables
Table 1: China biotechnology industry value: $ billion, 2016-20
Table 2: China biotechnology industry category segmentation: $ billion, 2020
Table 3: China biotechnology industry geography segmentation: $ billion, 2020
Table 4: China biotechnology industry value forecast: $ billion, 2020-25
Table 5: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: key facts
Table 6: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Annual Financial Ratios
Table 7: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Key Employees
Table 8: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 9: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 10: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 11: Sinovac Biotech Ltd.: key facts
Table 12: Sinovac Biotech Ltd.: Annual Financial Ratios
Table 13: Sinovac Biotech Ltd.: Key Employees
Table 14: Novo Nordisk A/S: key facts
Table 15: Novo Nordisk A/S: Annual Financial Ratios
Table 16: Novo Nordisk A/S: Key Employees
Table 17: Novo Nordisk A/S: Key Employees Continued
Table 18: China size of population (million), 2016-20
Table 19: China gdp (constant 2005 prices, $ billion), 2016-20
Table 20: China gdp (current prices, $ billion), 2016-20
Table 21: China inflation, 2016-20
Table 22: China consumer price index (absolute), 2016-20
Table 23: China exchange rate, 2016-20
List of Figures
Figure 1: China biotechnology industry value: $ billion, 2016-20
Figure 2: China biotechnology industry category segmentation: % share, by value, 2020
Figure 3: China biotechnology industry geography segmentation: % share, by value, 2020
Figure 4: China biotechnology industry value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the biotechnology industry in China, 2020
Figure 6: Drivers of buyer power in the biotechnology industry in China, 2020
Figure 7: Drivers of supplier power in the biotechnology industry in China, 2020
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in China, 2020
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in China, 2020
Figure 10: Drivers of degree of rivalry in the biotechnology industry in China, 2020
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
- Shanghai Kehua Bio-engineering Co Ltd
- Sinovac Biotech Ltd.
- Novo Nordisk A/S
Note: Product cover images may vary from those shown
